C12R 2001/36
Neisseria
C12R2001/36 (Neisseria) appears on 20 US grants and 35 published applications in this corpus.
Search patents in C12R- Granted patents
- 20
- Published applications
- 35
- Assignees
- 32
- Inventors
- 100
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 4 |
| 2021 | 1 | 1 |
| 2022 | 2 | 4 |
| 2023 | 1 | 3 |
| 2024 | 1 | 5 |
| 2025 | 0 | 3 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Outer membrane vesicles16 Jun 2026US 12,653,879 B2Glaxosmithkline Biologicals SA
- Meningococcal B recombinant vaccine6 Aug 2024US 12,053,516 B2Sanofi Pasteur Limited
- PapQuin-50 a quinoa grain-based bacterial growth medium nitrogen source26 Dec 2023US 11,851,645 B2
- Bacterial secretome for use in the treatment of skin lesions1 Nov 2022US 11,484,555 B2Pierre Fabre Dermo-Cosmetique
- Modified hexa-acylated neisserial LPS5 Apr 2022US 11,292,808 B2Intravacc B.V.
- Lower airway probiotics and methods of use for protection and treatment of respiratory disease16 Jul 2026US 2026/0199406 A1National Technology & Engineering Solutions of Sandia, LLC
- Methods for producing beta-cyclodextrins29 Jan 2026US 2026/0028655 A1Beren Therapeutics P.B.C.
- Microorganism having improved 3'-sialyllactose productivity and production method of 3'-sialyllactose20 Nov 2025US 2025/0354186 A1Kyowa Hakko Bio Co., Ltd.
- Legionaminic acid glycosyltransferases for chemoenzymatic synthesis of glycans and glycoconjugates19 Jun 2025US 2025/0197905 A1The Regents of the University of California
- Immunogenic compositions12 Jun 2025US 2025/0186572 A1Glaxosmithkline Biologicals SA
Most cited
By later US patents
- Test method for the laboratory diagnosis of Gonorrhea and test strain of neisseria gonorrhoeae18US 4,446,230 ATemple University of the Commonwealth System of Higher Education · 1984
- Method of producing an R-type bacteriocin and its use in the detection of specific microorganisms9US 4,142,939 AOregon State Board of Higher Education, An agency of the State of Oregon · 1979
- Neisseria mutants, lipooligosaccharides and immunogenic compositions8US 5,976,536 AEmory University · 1999
- Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae7US 4,696,896 ABactex, Inc. · 1987
- Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae6US 4,461,838 ABactex, Inc. · 1984